Chargement en cours...
Disease Characteristics, Patterns of Care, and Survival in Very Elderly Patients with Diffuse Large B-Cell Lymphoma
BACKGROUND: Although rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is considered standard therapy for diffuse large B-cell lymphoma (DLBCL), patterns of use and the impact of R-CHOP on survival in patients >80 years are less clear. METHODS: We used the Surveillanc...
Enregistré dans:
| Publié dans: | Cancer |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4441579/ https://ncbi.nlm.nih.gov/pubmed/25675909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29290 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|